PURA and PAOG Look To Tissue Culture Technology For Pharma Cannabis Cultivation
23 November 2021 - 6:08AM
InvestorsHub Cannabis NewsWire
Dallas, TX -- Nov. 22, 2021 -- Puration, Inc.
(OTC
Pink: PURA) and PAO Group, Inc. (OTC
Pink: PAOG) today announced plans to pursue tissue culture
technology for their pharmaceutical-grade cannabis cultivation
initiative. A recent announcement by
Pharmagreen Biotech, Inc. (OTC Pink: PHBI) got the attention of the
two companies.
“[PHBI] is in the business of providing the highest quality
starter plantlets utilizing a proprietary tissue culture process,
"Chibafreen", to licensed cannabis cultivators and to CBD / CBG
hemp farmers.”
PURA has launched a cooperative hemp industry branding strategy
under the name Farmersville
Hemp. PAOG is a CBD
pharmaceutical and nutraceutical technology
company that is a partner in PURA’s Farmersville Hemp
initiative.
PURA and PAOG are working together to build an extraction lab
and pharmaceutical-grade cultivation facility as part of the
Farmersville Hemp Brand facilities under construction in
Farmersville, Texas.
PURA and PAOG management, upon initial research, are optimistic
a tissue culture technology would add value to their overall
extract and cultivation initiative.
For more information on Puration, visit http://www.purationinc.com
Learn more about PAOG at www.paogroupinc.com
Disclaimer:
This News Release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause our
actual results, performance or achievements, or industry results,
to differ materially from any these statements. You are cautioned
not to place undue reliance on any those forward-looking
statements. Except as otherwise required by the federal securities
laws, we undertake no obligation to publicly update or revise any
forward-looking statements after the date of this news release.
None of such forward-looking statements should be regarded as a
representation by us or any other person that the objectives and
plans set forth in this News Release will be achieved or be
executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Jim DiPrima
888-272-6472
info@pao.group
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Oct 2024 to Nov 2024
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Nov 2023 to Nov 2024